Vicebio

Vicebio is an innovative clinical-stage biopharmaceutical company dedicated to the development of transformative multi-pathogen vaccines to combat respiratory viral infections. Leveraging its groundbreaking Molecular Clamp Technology, Vicebio is setting new standards in vaccine development by locking viral proteins in their optimal conformation. This allows Vicebio to create vaccines that offer broad protection, convenient ready-to-use administration, and efficient manufacturing processes.

Vicebio's lead program focuses on a cutting-edge multivalent vaccine designed to target five critical respiratory diseases. This positions Vicebio as a frontrunner in the creation of multipathogen respiratory vaccines, aimed at significantly reducing the global burden of respiratory illnesses. Vicebio's commitment to innovation and public health drives its mission to deliver best-in-class vaccines that protect communities worldwide.

The team at Vicebio is constantly striving for excellence in biotechnology research and development. We invite the management team at Vicebio to take the next step and create a customized and exclusive company showcase and product listing on our platform, further amplifying your reach and impact in the biopharmaceutical industry.